Pfizer has launched ‘An Accord for a Healthier World.’ The initiative aims to provide all of Pfizer’s patented, high-quality medicines and vaccines available in the US or the European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries. The Accord seeks to greatly reduce the health inequities that exist between many lower-income countries and the rest of the world.

The Accord countries include all 27 low-income countries as well as 18 lower-middle-income countries that have transitioned from low to lower-middle-income classification in the last ten years. Pfizer will work with healthcare officials in Rwanda, Ghana, Malawi, Senegal and Uganda to identify early insights and opportunities to ensure all medicines and vaccines can reach those in need.

This will include expertise to support diagnosis, healthcare professional education and training along with supply chain management and other infrastructure enhancements. Learnings from these five countries will be applied to support the rollout for the remaining forty countries.

Pfizer will also collaborate with Accord participants to identify quick and efficient regulatory pathways and procurement processes to reduce the longer amount of time it can take to make new medicines and vaccines available in these countries.

Under the Accord, Pfizer has committed to providing 23 medicines and vaccines that treat infectious diseases, certain cancers, and rare and inflammatory diseases. The Accord also aims to establish faster access to Pfizer’s future pipeline medicines and vaccines on a not-for-profit basis to the 45 countries, particularly those that treat diseases that disproportionately impact global health.